Australia - English SELECT A COUNTRY

NEW APPROACHES, NEW IDEAS

Research and innovation drive AbbVie's business as a global biopharmaceutical company.

We always look beyond the products we make in order to find better solutions for treating some of the world’s toughest diseases. At AbbVie, we focus on developing medicines that deliver strong clinical performance, provide significant benefits for patients and deliver economic value, particularly where there is significant need. Our expertise in both small molecules and biologics gives us the flexibility to find and pursue the best solution for patients.

AbbVie recognises the strength and capability of local medical researchers and selected Australia as one of only ten countries for global Phase II and III clinical trials of its industry-leading bio-pharmaceuticals pipeline; a testament to the world-leading medical institutions here in Australia.

We are currently testing 17 compounds in around 85 studies, with more than 1000 patients enrolled at 300 sites across Australia.

We understand that progress often comes more quickly working together than alone. That’s why we collaborate with external researchers, other companies, medical societies, patient advocates and many other stakeholders to gain a better understanding of how we can make the most significant contributions.


focusimg2_03

FOCUS AREAS

Our core therapeutic areas include Liver Disease, neuroscience, immunology and oncology.

Learn more »

focusimg_02

PATIENT FOCUS

We’re committed to helping patients lead healthier lives.

View patient focus »

focusimg_03

RESEARCH & DEVELOPMENT

Our efforts are focused on areas where we believe we can have an even greater impact on the disease and how it is managed.

See our process »

Leave abbvie.com.au

The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The AbbVie Internet site that you have requested may be in a language that differs from your country of origin.

The AbbVie Internet site that you have requested may not be optimised for your screen size.

Do you wish to continue to this AbbVie site?

Exit abbvie.com.au

The product-specific Internet site that you have requested is intended for the residents of Australia. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The product-specific Internet site that you have requested may not be optimised for your screen size.

Do you wish to continue to this product-specific site?